Q2 EPS Forecast for Relay Therapeutics Decreased by Analyst
Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) – Stock analysts at Leerink Partnrs decreased their Q2 2025 earnings per share estimates for shares of Relay Therapeutics in a research note issued to investors on Monday, May 5th. Leerink Partnrs analyst A. Berens now expects that the company will post earnings per share of ($0.37) for […]
Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) – Stock analysts at Leerink Partnrs decreased their Q2 2025 earnings per share estimates for shares of Relay Therapeutics in a research note issued to investors on Monday, May 5th. Leerink Partnrs analyst A. Berens now expects that the company will post earnings per share of ($0.37) for […]
